undefined

points

[-]

I'm pretty optimistic. I think it's a threshold question where we need a number of basic technologies to all get over certain bars before the floodgates start to open.

Over the past 1-2 decades there has been unbelievable progress at the basic technology level but most people are unimpressed because they haven't translated yet due to not individually being sufficient to cause an explosion of progress. IMO, we're starting to see it finally as so many different technologies have gotten so cheap, fast, and good.

by visha1v2 hours ago|

parent|

[-]

the public experiences biotechnology as decades of nothing, followed by years of everything once bottlenecks align

by toponijo2 minutes ago|

parent|

[-]

I think it's just a tech thing! Same as when the internet really got going or what's happening with AI

by dylan6042 hours ago|

parent|

prev|

[-]

So we're waiting for the Apple of the medical world to take a bunch of preexisting things to be applied together in a way that makes the whole much more valuable than the pieces. Or we need all of the individual lions to come together to make the Voltron?

by mattlondon2 minutes ago|

parent|

[-]

I think realistically we're waiting for someone in the top 10-20 richest people in the world to get cancer (or a close relative etc) who will then throw billions at research to try and fix the problem.

by ben_w1 hours ago|

parent|

prev|

[-]

Usually it takes about a decade for most medical inventions to work their way through medical bureaucracy[0], so I'd say that 10 years ago we were at the stage of watching Matthew Broderick war-dialling with an acoustic coupler and reading Usborne Books telling us that criminals of the future would work from home, and today we're in the exciting early days of dialup, AltaVista, and GeoCities[1].

[0] The covid vaccines collectively were faster only due to the fact that when money is no object you can parallelise a lot of options and can pipeline the testing stages rather than waiting for full review and another funding round before progressing to the next stage

[1] Where they-don't-tile-but-we-did-it-anyway animated gif backgrounds are the metaphor for home kits to make random things bioluminescent: https://www.the-odin.com/gfp-bacteria/

by smm112 hours ago|

parent|

prev|

[-]

We already had this. It was called Theranos.

by fragmede2 hours ago|

parent|

[-]

I don't know if we "had" something called Theranos. In fact, I believe that was the subject of a couple of lawsuit because we didn't.

by rowanG0772 hours ago|

parent|

prev|

[-]

I'm not sure what this comment is trying to say. Theranos was a company build from the ground up on fraud. Apple, for all its faults, is provably at the forefront of technology used in personal computing devices.

by huxley1 hours ago|

parent|

[-]

I think you've captured exactly what they are trying to say

by rowanG07714 minutes ago|

parent|

[-]

This doesn't exactly make it clearer. I can think of two things it can imply. Neither make a lick of sense:

- Theranos was at the forefront of medical technology

- Apple is a fraudulent company to the core

by im3w1l51 minutes ago|

parent|

prev|

[-]

Apple is first and foremost an affordable luxury brand that makes sleek hardware.

by rowanG07713 minutes ago|

parent|

[-]

And theranos did that too? Theranos, a medical company, was an affordable luxury (??) brand that makes sleek hardware? In fact the hardware was not sleek at all, since it didn't function.

by anovikov2 hours ago|

parent|

prev|

[-]

The floodgates open = the market will see that at least some of that can actually work and make money => they will pour funding => new approaches built on that funding will start working, too?

by colechristensen3 hours ago|

prev|

[-]

Real in vivo genetic engineering isn't going away and will indeed be a powerful tool to face cancer. Any particular effort is doubtful because this is a journey measured in decades. It is not the same story as any one particular wonder drug fizzling out to nothing, it is a class of tools that is maturing into the realm of early therapeutic deployment.